FDA News

Latest News

FDA Approves RSV Vaccine for Older Adults
FDA Approves RSV Vaccine for Older Adults

June 1st 2023

The approval for Abrysvo represents the second RSV vaccine approved for adults aged 60 years and older in the last month.

Deepak Bhatt, MD, MPH | Credit: Mount Sinai Heart
Exploring the Impact of the Sotagliflozin Approval, with Deepak Bhatt, MD, MPH

May 27th 2023

US Food and Drug Adminstration logo in black over a white background | Credit: Food and Drug Administration
FDA Approves Sotagliflozin for Treatment of Heart Failure

May 26th 2023

Stock imagery depicting the word "Heart Failure" written on a doctor's note pad surrounded by medical imagery | Credit: Fotolia
The Prospect of SGLT1/2i in Heart Failure: Cardiologists Await FDA Decision on Sotagliflozin

May 26th 2023

FDA Approves High-Concentration, Citrate-Free Biosimilar Adalimumab-aaty
FDA Approves High-Concentration, Citrate-Free Biosimilar Adalimumab-aaty

May 24th 2023

Podcasts
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue

More News

© 2023 MJH Life Sciences

All rights reserved.